Skip to main content

Outset Medical Inc

For the period ended Dec 31, 2024. Filed Feb 28, 2025.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2024 · Filed Feb 28, 2025

OM$4.12-2.6%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Statements of Operations

(in thousands, except per share amounts)

Years Ended December 31,
202420232022
Revenue:
Product revenue$80,977$103,537$93,388
Service and other revenue32,71226,83921,987
Total revenue113,689130,376115,375
Cost of revenue:
Cost of product revenue46,44974,45482,510
Cost of service and other revenue28,67626,92215,032
Total cost of revenue75,125101,37697,542
Gross profit38,56429,00017,833
Operating expenses:
Research and development38,39757,30748,855
Sales and marketing70,04496,23289,482
General and administrative43,49845,23140,515
Total operating expenses151,939198,770178,852
Loss from operations(113,375)(169,770)(161,019)
Interest income and other income, net9,76110,1713,291
Interest expense(23,871)(12,675)(3,566)
Loss on extinguishment of term loan——(1,367)
Loss before provision for income taxes(127,485)(172,274)(162,661)
Provision for income taxes491523295
Net loss$(127,976)$(172,797)$(162,956)
Net loss per share, basic and diluted$(2.46)$(3.48)$(3.38)
Shares used in computing net loss per share, basic and diluted51,95149,588$48,161
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.